Naturewise Biotech & Medicals (ROCO:4732) OCF Yield %: -13.61 (As of Jul. 07, 2026)


ROCO:4732 Naturewise Biotech & Medicals Corp ROCO:4732
62 GF Score
Price NT$17.00
GF Value NT$22.10
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Naturewise Biotech & Medicals OCF Yield %?

Naturewise Biotech & Medicals ROCO:4732 -2.02% 62 OCF Yield % is -13.61 as of Jul. 07, 2026. GuruFocus rates ROCO:4732 with a GF Score™ of 62/100 and a GF Value™ of NT$22.10 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 1,409 Biotechnology companies, Naturewise Biotech & Medicals ranks worse than 61.11% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Naturewise Biotech & Medicals's Trailing 12-Month Cash Flow from Operations is NT$-111.7 Mil, and Market Cap is NT$821.1 Mil. Therefore, Naturewise Biotech & Medicals's OCF Yield % for today is -13.61%.

The historical rank and industry rank for Naturewise Biotech & Medicals's OCF Yield % or its related term are showing as below:

ROCO:4732' s OCF Yield % Range Over the Past 10 Years
Min: -16.09   Med: -0.22   Max: 5.79
Current: -13.61


During the past 13 years, the highest OCF Yield % of Naturewise Biotech & Medicals was 5.79%. The lowest was -16.09%. And the median was -0.22%.

ROCO:4732's OCF Yield % is ranked worse than
61.11% of 1409 companies
in the Biotechnology industry
Industry Median: -7.99 vs ROCO:4732: -13.61

Naturewise Biotech & Medicals's OCF Margin % for the quarter that ended in Dec. 2025 was %.


Naturewise Biotech & Medicals OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Naturewise Biotech & Medicals OCF Yield % Related Terms


Naturewise Biotech & Medicals OCF Yield % Historical Data

* Premium members only.

The historical data trend for Naturewise Biotech & Medicals's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Naturewise Biotech & Medicals OCF Yield % Chart

Naturewise Biotech & Medicals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.37 0.80 4.58 -0.20 -11.30

Naturewise Biotech & Medicals Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.30 2.31 -2.53 -0.77 -21.74

ROCO:4732 vs VRTX, REGN, ALNY: OCF Yield % Comparison

For the Biotechnology subindustry, Naturewise Biotech & Medicals's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Naturewise Biotech & Medicals OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Naturewise Biotech & Medicals's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Naturewise Biotech & Medicals's OCF Yield % falls into.


ROCO:4732
62GF Score
Naturewise Biotech & Medicals Corp ROCO:4732
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Naturewise Biotech & Medicals OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Naturewise Biotech & Medicals's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-111.74 / 989.1045
=-11.30%

Naturewise Biotech & Medicals's annualized OCF Yield % for the quarter that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-107.518 * 2 / 989.1045
=-21.74%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -13.61 mean?
Naturewise Biotech & Medicals (ROCO:4732) has a OCF Yield % of -13.61 as of Jul. 07, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Naturewise Biotech & Medicals and its competitors. According to the industry distribution chart, Naturewise Biotech & Medicals ranks #861 out of 1409 companies in the Biotechnology industry, placing it in the top 61.1%.
Is Naturewise Biotech & Medicals' OCF Yield % too high?
Naturewise Biotech & Medicals' current OCF Yield % is -13.61. Based on the distribution chart, Naturewise Biotech & Medicals ranks #861 out of 1409 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Naturewise Biotech & Medicals has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Naturewise Biotech & Medicals' OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Naturewise Biotech & Medicals ranks #861 out of 1409 companies for OCF Yield %. This places Naturewise Biotech & Medicals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Naturewise Biotech & Medicals and its competitors. Naturewise Biotech & Medicals's current OCF Yield % is -13.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Naturewise Biotech & Medicals stock overvalued right now?
Based on GuruFocus' analysis, Naturewise Biotech & Medicals (ROCO:4732) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$22.10, compared to a current price of NT$17.00 — trading 23.1% below its estimated fair value. The current OCF Yield % is -13.61. Naturewise Biotech & Medicals' overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Naturewise Biotech & Medicals (ROCO:4732), the current OCF Yield % is -13.61 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Naturewise Biotech & Medicals (ROCO:4732) Overvalued in 2026?

Based on GuruFocus' analysis, Naturewise Biotech & Medicals stock appears to be undervalued. The current stock price of NT$17.00 is trading 23.1% below its estimated GF Value™ of NT$22.10. GuruFocus considers Naturewise Biotech & Medicals to be Modestly Undervalued.

Key valuation signals for ROCO:4732:

  • OCF Yield %: -13.61
  • GF Value™: NT$22.10 vs. price of NT$17.00 (23.1% below fair value)
  • GF Score™: 62/100 with 3 warning signs

No single metric tells the full story. See the ROCO:4732 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Naturewise Biotech & Medicals Business Description

Address No. 36, Bade Road, 6th Floor, Section 3, Songshan District, Taipei, TWN, 105
Naturewise Biotech & Medicals Corp is a Taiwan-based drug development company that focuses on botanical drug and small molecule therapies. Its products include NBM-BMX Oral Softgel Capsule, Lipocol Forte Capsule, and PPLs Taiwan Green Propolis.
62GF Score

Get the complete analysis for ROCO:4732

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$17.00
Price
NT$22.10
GF Value